In these reported cases, our therapeutic decision was driven by our previous favourable experience in patients with more preserved renal function [8] and by the fact that these patients, who had CKD and proteinuria persistently higher than 1 g/day despite inhibition of the renin-angiotensin system (RAS), were at high risk to rapidly progress to ESRD. The gene discussed is REN; the disease is chronic kidney disease.